Company: HROW
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001641172-25-022980
Chunk: 14

Company: HARROW, INC.
Filing Date: 2025-08-11
Form: 10-Q
Item: Item 1
Chunk 14
---
, 2024 

    Carrying Value  
    Fair Value  
    Carrying Value  
    Fair Value 
  
    2026 Notes 
    $74,389,000  
    $76,560,000  
    $74,002,000  
    $75,840,000 
  
    2027 Notes 
    $38,484,000  
    $42,391,000  
    $38,130,000  
    $42,198,000 
  
    Oaktree Loan 
    $109,229,000  
    $113,488,000  
    $107,407,000  
    $112,932,000 

The
Company’s other financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses,
accrued payroll and related liabilities, deferred revenue and customer deposits and operating lease liabilities. The carrying amount
of these financial instruments, except for operating lease liabilities, approximates fair value due to the short-term maturities of these
instruments. Based on borrowing rates currently available to the Company, the carrying value of the operating lease liabilities approximate
their respective fair values.

Basic
and Diluted Net Income (Loss) per Common Share

Basic
net income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders for the period by
the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed by
dividing the net income (loss) attributable to common stockholders for the period by the weighted average number of common and
common equivalent shares, such as stock options, restricted stock units (“RSUs”), performance stock units
(“PSUs”), and warrants, outstanding during the period. Common equivalent shares (using the treasury stock method) from
stock options, unvested RSUs, unvested PSUs and warrants were 2,816,409
and 4,488,940
for the six-months ended June 30, 2025 and the three and six-months ended June 30, 2024, respectively, and are excluded in the
calculation of diluted net loss per common share for the periods presented, because the effect is anti-dilutive. Included in the
basic and diluted net income (loss) per share calculation were RSUs awarded to directors that had vested, but the issuance and